DELCF - Delic Holdings Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0040
0.0000 (0.00%)
As of 01:46PM EDT. Market open.
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close0.0040
Open0.0040
BidN/A x N/A
AskN/A x N/A
Day's Range0.0040 - 0.0040
52 Week Range0.0031 - 0.0649
Volume50,120
Avg. Volume162,671
Market Cap352,110
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0300
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for DELCF

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Business Wire

    Delic Holdings Corp. Signs LOI with Peter/PetraMD to Acquire Ketamine Wellness Centers and Facilitate Online Ketamine Treatments Nationwide

    VANCOUVER, British Columbia, April 03, 2023--Peter/PetraMD, the largest online provider of hormone therapy for men and women in the United States, today announced the intent to acquire Ketamine Wellness Centers. If successful, the acquisition would represent an incredible on-ramp into the ketamine space for Peter/PetraMD. With over 20 years of experience and nearly 100,000 patients across the United States, Ketamine Wellness Centers is the largest ketamine infusion therapy provider in the US and

  • CNW Group

    IIROC Trade Resumption - DELC

    Trading resumes in:

  • CNW Group

    IIROC Trading Halt - DELC

    The following issues have been halted by IIROC:

  • CNW Group

    Delic Labs President and CSO Dr. Markus Roggen to Discuss the Importance of R&D for Business Growth at MJBizCon

    Delic Holdings Corp ("Delic" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, today shared details regarding Delic Labs President and CSO Dr. Markus Roggen's participation at the 11th annual MJBizCon in Las Vegas, Nevada on November 15, 2022.

  • PR Newswire

    Ketamine Wellness Centers (KWC) Expands Insurance Coverage with Medicare for Ketamine Therapy Patients

    Ketamine Wellness Centers (KWC), the largest ketamine therapy provider in the U.S. and a subsidiary of Delic Holdings Corp ("Delic" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), has become one of a few ketamine therapy providers in the U.S. to offer Medicare coverage to patients at eight KWC clinics across the country — Chicago, Denver, Houston, Jacksonville, Minneapolis, Tucson, Salt Lake City and Seattle.

  • PR Newswire

    Ketamine Wellness Centers (KWC) Partners with Veterans Administration Community Care Network (VA-CCN) To Expand SPRAVATO® Coverage

    Ketamine Wellness Centers (KWC), the largest ketamine therapy provider in the U.S. and a subsidiary of Delic Holdings Corp ("Delic" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), has expanded its partnership with the Veterans Administration Community Care Network (VA-CCN) to cover SPRAVATO® treatments at select clinics. The partnership will allow VA-CCN patients experiencing treatment-resistant depression (TRD) to access treatments with prior authorization from the VA-CCN at the follow

  • CNW Group

    Delic Corp to Present on Strategy and Expansion of Nation's Largest Ketamine Clinic Network at H.C. Wainwright Annual Global Investment Conference

    Delic Holdings Corp ("Delic" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, confirmed details regarding Delic Corp Executive Chairman Matt Stang's virtual attendance at the 24th annual H.C. Wainwright Annual Global Investment Conference on September 12-14, 2022.

  • CNW Group

    Delic Executive Chairman Matt Stang Named to World Biz Magazine's Top 100 CEOs in Innovation

    Delic Holdings Corp ("Delic" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, today celebrated Matt Stang, recently named Executive Chairman of Delic Corp, as one of World Biz Magazine's Top 100 CEOs in Innovation in 2022. Stang has been recognized as a champion of creativity who is committed to making a positive environmental and social impact through his work.

  • CNW Group

    Delic Announces Postponement of Meet Delic Conference

    Delic Holdings Corp ("Delic" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, today announced the postponement of the Meet Delic conference taking place November 5 and 6 at AREA15 in Las Vegas, Nevada. The conference will now be held on October 14 and 15, 2023, in the same location. Tickets purchased for 2022 Meet Delic will be honored at next year's event and current Early Bird pricing has been extended for an additional 30 da

  • PR Newswire

    Delic Announces Two Key Executive Appointments

    Delic Holdings Corp ("Delic" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, today shared details regarding two executive appointments. Matt Stang, co-founder and CEO of Delic, has been appointed to the role of Executive Chairman. Kevin Nicholson, COO of Delic, will transition into the role of Chief Executive Officer in addition to joining the company's Board of Directors. He also serves as the CEO of Ketamine Wellness Centers

  • PR Newswire

    DELIC COMPLETES OFFERING OF DEBENTURES

    Delic Holdings Corp ("Delic" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, is pleased to announce that it completed the sale of 1,240 units (the "Units") at a price of $1,000 per Unit for aggregate gross proceeds of $1,240,000, on July 27, 2022 (the "Closing Date"). Each Unit consists of one 4.0% senior secured, $1,064 ‎principal amount convertible debenture (a "‎Debenture") and 16,369 share purchase warrants ("Warrants").

  • CNW Group

    Delic 2021 Revenue Shows Strong Growth as Nation's Largest Ketamine Clinic Chain, Continues Expansion of Mental Health Wellness Services

    Delic Holdings Corp ("DELIC" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, is pleased to share the following corporate update:

  • CNW Group

    Delic Labs President and CSO Dr. Markus Roggen Named to Cannabis Scientist Power List for Third Consecutive Year

    Delic Holdings Corp ("Delic" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, today celebrated Dr. Markus Roggen, President and Chief Science Officer for Delic Labs, being named to the Cannabis Scientist Power List for the third consecutive year. Dr. Markus Roggen is consistently recognized as one of the most influential figures in the processing professionals category because of his commitment to creating a body of work on can

  • PR Newswire

    Ketamine Wellness Centers (KWC) Launches Ketamine Wellness Integrative Therapist Directory

    Ketamine Wellness Centers (KWC), the largest ketamine therapy provider in the U.S. and a subsidiary of Delic Holdings Corp ("Delic" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), today officially launched the Ketamine Wellness Integrative Therapist Directory. The comprehensive resource will connect KWC patients with qualified mental health practitioners who can help them process and integrate the benefits of ketamine therapy into their everyday life.

  • CNW Group

    Delic Corp to Present Vision for Long-Term Growth and Industry-Leading Clinic Developments at First Annual H.C. Wainwright Mental Health Conference

    Delic Holdings Corp ("Delic" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, confirmed details regarding Delic Corp CEO Matt Stang's virtual attendance at the first annual H.C. Wainwright Mental Health Conference on June 27, 2022.

  • PR Newswire

    Delic Labs to Present on Psychedelics, Cannabis Extraction at Grow Up Conference and Expo

    Delic Holdings Corp ("Delic" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, today shared details regarding Dr. Markus Roggen, President and Chief Scientific Officer of Delic Labs, and his participation in the upcoming Grow Up Conference and Expo.

  • CNW Group

    Ketamine Wellness Centers (KWC) Launches SPRAVATO® Nasal Spray Therapy in Minneapolis, Salt Lake City and Dallas

    Ketamine Wellness Centers (KWC), the largest ketamine therapy provider in the U.S. and a subsidiary of Delic Holdings Corp ("Delic" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), has expanded the availability of SPRAVATO® to three new cities and increased the total number of clinics offering the FDA-approved esketamine nasal spray to six. Starting June 1, the KWC clinics in Minneapolis, Salt Lake City and Dallas will join the Houston, Las Vegas and Seattle locations in offering SPRAVAT